← Back to Bills
HR 4534118th CongressFailed / ExpiredHouse

Women and Lung Cancer Research and Preventive Services Act of 2024

Policy Area: Health
View on Congress.gov
Origin Chamber
House
Last Updated
Dec 5, 2025
Latest Action Date
Dec 17, 2024

Latest Action

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The Women and Lung Cancer Research and Preventive Services Act of 2024 is a House bill from the 118th Congress focused on health policy, specifically targeting lung cancer research and preventive services for women. The bill was received in the Senate, read twice, and referred to the Committee on Health, Education, Labor, and Pensions. However, the bill ultimately failed or expired without further legislative action. No official summary or full text is available to provide detailed provisions or specific programmatic elements.

Bottom Line

This bill aimed to address lung cancer research and prevention for women but did not advance beyond committee referral in the Senate and expired without enactment.

Policy Risk Level
🟢 Low
Neutral Risk Assessment
Key Points
  • The bill focuses on lung cancer research and preventive services specifically for women.
  • It was introduced in the House during the 118th Congress and referred to the Senate committee after initial House consideration.
  • The bill did not pass and is currently classified as failed or expired.
Who Benefits?

['Women potentially at risk for lung cancer', 'Health research institutions focused on lung cancer', 'Public health agencies involved in cancer prevention and research']

Potential Concerns

['Lack of available full text limits understanding of specific funding, authority, or programmatic mechanisms.', 'No information on cost, oversight, or enforcement provisions is available.', "The bill's failure to pass means no direct policy or funding changes were implemented."]

Political Context

The bill was introduced in the House and subsequently referred to the Senate Committee on Health, Education, Labor, and Pensions but did not advance further. It is categorized as failed or expired, indicating it did not receive a vote or enactment during the 118th Congress. The legislative focus aligns with ongoing health policy efforts to address cancer prevention and research, particularly targeting women's health issues.

Hidden Impact Review

Hidden impact flags detected: 2

GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

2 Detected
Detected Flags
Indirect Effects

["Potential increased focus on women's lung cancer research if similar legislation is introduced in the future.", 'Possible influence on public health priorities related to gender-specific cancer prevention efforts.']

GovScope Watchdog Notes

The absence of both the full bill text and an official summary limits transparency and public understanding of the bill's specific provisions and intended impact. The bill's failure to progress beyond committee referral further restricts available information on implementation or oversight mechanisms.

Passage Likelihood: LowConfidence: 75%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready